Docstoc

Evaluation of “Deadly Trio” Chronic Disease Management and

Document Sample
Evaluation of “Deadly Trio” Chronic Disease Management and Powered By Docstoc
					 Evaluation of “Deadly Trio”
Chronic Disease Management
and Cardiovascular Screening
   Report to PEC Board – 19th November
                  2009

   Amanda Lambert, Public Health Analyst
CHD prevalence vs QOF prevalence
            2005/06
     Chronic disease management
   Red reports issued to 5,410 (53%) of those on Deadly
    Trio registers
   Number not adequately treated reduced by 2,500
   Variation in statin prescribing due to: GP, concomitant
    aspirin, smoking, BP, cholesterol level
   Variation in aspirin prescribing due to: GP,
    concomitant statin, ethnicity, age
   No change in lifestyle factors ie weight and smoking
    Numbers with multiple risk factors
   6,600 with known CHD
       950 of these were smokers
          70 of these had BMI > 35
          430 had BP > 130
          450 had cholesterol > 4

   15,000 with known diabetes
       1,800 smokers
          200 BMI > 35
          880 BP > 130
          890 cholesterol > 4
                   Screening
   6,300 screened, response rate 24%
   3,500 screened by GP
   Uptake varied by practice
   Uptake higher where:
     GP had LES
     Phone numbers recorded
     Ethnicity recorded
     Black/Asian
     Non-smoker
             Outcomes of Screening
   Screened men at risk
       more likely to be placed on disease register (13% vs
        6%)
            Reducing the number with undiagnosed long term
             conditions
       29% eligible for statins, 26% eligible for aspirin
                 So far 38% of those eligible for statin (25% for aspirin) have
                  been prescribed them

   GP screening improves prescribing rates
                   Lack of HDL
   GPs send blood to several labs
   The following illustrates variation due to lab
    non-compliance
       HDL missing
          61% from UHB
          15% from City
    Translating evaluation into practice
   LES encourages GP screening
   Frequent red reports can cover more treatment areas
        Automated reporting
   Electronic feedback from alternative provider to GP
   GP and practice training
   Lab performance
   Improved lifestyle management
        My Action programme

				
DOCUMENT INFO